Valuation : Edwards Lifesciences Corporation

Market Cap 52.31B 45.03B 42.28B 38.61B 72.45B 4,977B 73B 501B 195B 2,525B 196B 192B 8,356B P/E 2026 *
35.9x
P/E 2027 * 27.5x
Enterprise Value 48.68B 41.9B 39.35B 35.93B 67.42B 4,632B 67.93B 466B 181B 2,350B 183B 179B 7,776B EV / Sales 2026 *
7.2x
EV / Sales 2027 * 6.34x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day+0.60%
1 week+1.07%
Current month+5.44%
1 month+4.41%
3 months+4.95%
6 months+4.09%
Current year+6.45%
1 week 89.32
Extreme 89.315
92.12
1 month 86.39
Extreme 86.39
93.91
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap. Importance
8/28/26 Sell

Executive/Senior Manager

-2,644 0.0005%
8/26/26 Sell

Executive/Senior Manager

-1,240 0.0002%
8/26/26 Exercice

Executive/Senior Manager

95,400 0.0166%
Change 5-day change 1-year change 3-year change Capi.($)
+0.60%+1.07%+11.57%+16.62% 52B
-0.82%-1.93%+25.24%+10.39% 230B
-1.16%-2.42%+3.76%-19.16% 152B
+1.14%+0.88%-19.66%+20.53% 132B
+3.12%-4.11%-54.22%-11.00% 67.88B
-0.99%-3.12%-17.97%-15.39% 51.05B
-0.18%-3.42%+22.20%+25.17% 43.38B
-0.01%+0.96%+37.39%+44.37% 40.74B
-0.10%+3.71%-12.54%+46.24% 34.67B
-0.91%-4.30%+118.39%+29.30% 32.55B
Average +0.07%-1.25%+11.42%+14.71% 83.58B
Weighted average by Cap. -0.08%-1.47%+6.82%+8.34%

Financials

2026 *2027 *
Net sales 6.76B 5.82B 5.46B 4.99B 9.36B 643B 9.43B 64.7B 25.16B 326B 25.38B 24.83B 1,080B 7.43B 6.4B 6.01B 5.48B 10.29B 707B 10.37B 71.11B 27.65B 359B 27.89B 27.29B 1,187B
Net income 1.44B 1.24B 1.16B 1.06B 1.99B 137B 2B 13.74B 5.34B 69.27B 5.39B 5.27B 229B 1.9B 1.63B 1.53B 1.4B 2.63B 180B 2.65B 18.15B 7.06B 91.55B 7.12B 6.97B 303B
Net Debt -3.63B -3.13B -2.94B -2.68B -5.03B -345B -5.07B -34.75B -13.51B -175B -13.63B -13.34B -580B -5.19B -4.47B -4.2B -3.83B -7.2B -494B -7.25B -49.72B -19.34B -251B -19.5B -19.08B -830B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-08-31 US$90.75 +0.60% 3,913,591
26-08-28 US$90.21 +0.29% 2,043,703
26-08-27 US$89.95 -0.91% 3,059,265
26-08-26 US$90.78 -0.10% 2,778,784
26-08-25 US$90.87 +0.41% 2,389,753
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
90.75USD
Average target price
100.96USD
Spread / Average Target
+11.25%

Quarterly revenue - Rate of surprise